Press Releases May 27, 2026 07:00 AM

Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026

Balchem Corporation to Present at Wells Fargo Industrials Conference on June 10, 2026

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
BCPC

Balchem Corporation announced its participation in the Wells Fargo Industrials Conference on June 10, 2026, where key executives including the CEO, CFO, and Senior Director of Investor Relations will present. The company is a global specialty ingredient manufacturer serving health and nutrition markets with three main business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
BCPC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Balchem Corporation will participate in the Wells Fargo Industrials Conference, allowing direct communication with investors and analysts.
  • The company operates in three main segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, serving diverse industries such as food, supplements, pharmaceuticals, animal health, and agriculture.
  • Top leadership, including the CEO and CFO, will engage with the market, potentially highlighting recent developments and future strategies.

MONTVALE, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the Wells Fargo Industrials Conference on June 10, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Contact:Jacqueline Yarmolowicz Balchem Corporation (Telephone: 845-326-5600)



Risks

  • Market reaction is uncertain as this is primarily an investor relations event without new product or financial announcements.
  • The company operates in multiple sectors (nutrition, animal health, specialty chemicals), exposing it to sector-specific regulatory and supply chain risks.
  • Economic or market conditions may impact the effective reception of the company’s presentation at the conference.

More from Press Releases

Trump Media Settles Legal Disputes Jul 19, 2026 GEnx-1B Engines Surpass 50 Million Flight Hours Jul 19, 2026 XA Investments President Kimbery Flynn Speaks to Shareholders About XFLT Proxy Vote Jul 19, 2026 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population Jul 18, 2026 UFC Names Meridian Holdings Official Sponsor of Fight Night Belgrade Jul 18, 2026